Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Koehler, CA
Jeffrey Alan Koehler, Pasadena, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100062156 | Reverse Osmosis Membranes - Reverse osmosis membranes made by interfacial polymerization of a monomer in a nonpolar (e.g. organic) phase together with a monomer in a polar (e.g. aqueous) phase on a porous support membrane. Interfacial polymerization process is disclosed for preparing a highly permeable RO membrane, comprising: contacting on a porous support membrane, a) a first solution containing 1,3-diaminobenzene, and b) a second solution containing trimesoyl chloride, wherein at least one of solutions a) and b) contains nanoparticles when said solutions are first contacted, and recovering a highly permeable RO membrane. | 03-11-2010 |
Jeffrey Allan Koehler, Pasadena, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110005997 | HYBRID TFC RO MEMBRANES WITH NITROGEN ADDITIVES - RO membranes using chlorinated water as a feed stream maybe protected from damage by the chlorine with a protective layer including reactive nitrogen which forms chloromines on the surface of the membrane that reduce chlorine penetration. This protective layer also provides substantial anti-fouling capabilities, whether used with a chlorinated or unchlorinated feed stream because the chloramines are anti-bacterial. Although chlorine is lost in use, the anti-fouling layer or coating can be recharged with additional chlorine without damaging the discrimination layer. The anti-fouling layer or coating may be advantageously used with Thin film composite, TFC, membranes for use in forward and reverse osmosis may include nanoparticles, monohydrolyzed and/or di-hydrolyzed TMC, and/or alkaline earth alkaline metal complexes or other additives. | 01-13-2011 |
Loren M. Koehler, Falr Oaks, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110145422 | MANAGEMENT PROCESSORS COOPERATING TO CONTROL PARTITION RESOURCES - Systems, methods and computing components are provided for allocating a plurality of computing components among one or more logical partitions. Each of the plurality of computing components may have a management processor that is configured to assume a role among management processors of a partition. Each management processor may then cooperate with other management processors of the partition to control resources of the partition. | 06-16-2011 |
Loren M. Koehler, Fair Oaks, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110093572 | LOW LEVEL INITIALIZER - Various embodiments of a method of configuring a predefined set of electrically isolated blades to function as a single blade are described. In one embodiment, a configuration rule is accessed, wherein a portion of the configuration rule assigns roles to management processors coupled with the predefined set of conjoined blades of a blade partition. Assistant management processors are directed to configure blade manageability modules to support the assigned roles. The blade manageability modules are coupled with the management processors. In one embodiment, the assistant management processors are directed to configure resources to be shared across the blade partition according to the configuration rule. After determining that the conjoined blades are configured according to the configuration rule, the conjoined blades are initialized. Thus, the conjoined blades are coordinated to function as a single blade. | 04-21-2011 |
| 20110093574 | MULTI-BLADE INTERCONNECTOR - Various embodiments of the present technology, a method [ | 04-21-2011 |
| 20110113160 | DOMAIN MANAGEMENT PROCESSOR - Various embodiments of a method [ | 05-12-2011 |
| 20110145467 | INTERCONNECTING COMPUTING MODULES TO FORM AN INTEGRATED SYSTEM - Systems, methods and portable devices are provided for interconnecting one or more computing modules within an enclosure together to form an integrated system. A portable device may include a communication interface configured to be removably coupled to each computing module for interconnecting them together to form the integrated system. A portable device may also include memory configured to store an integrated system personality that serves as a point of authority for each computing module of the integrated system. The integrated system personality may include an identifier of the integrated system. | 06-16-2011 |
| 20110145540 | DYNAMICALLY REALLOCATING COMPUTING COMPONENTS BETWEEN PARTITIONS - Systems, methods and computing components are provided for dynamically reallocating a plurality of computing components among one or more logical partitions. A first computing component that is allocated to a first partition may have a management processor. A second computing component may be allocated to a second partition. The management processor of the first computing component may be configured to reallocate the first computing component to a third partition without affecting the second computing component. | 06-16-2011 |
Michael Koehler, Palo Alto, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110201593 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF - The invention provides novel compounds of formula I having the general formula: | 08-18-2011 |
Michael F.t. Koehler, Palo Alto, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090221630 | IAP INHIBITORS - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula (I): wherein Q, X | 09-03-2009 |
| 20100069357 | PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE - Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR). | 03-18-2010 |
| 20100130539 | IMIDAZOPYRIDINE INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula I: wherein Q, X | 05-27-2010 |
| 20100331305 | OXO-HETEROCYCLE FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE - Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR). | 12-30-2010 |
| 20110098305 | ARYLSULFONAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE - Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member. | 04-28-2011 |
Michael F.t. Koehler, Burlingame, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080261989 | Quinoxaline Inhibitors of the Hedgehog Signalling - The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I wherein A is a carbocycle or heterocycle; X is alkylene, NR | 10-23-2008 |
Michael F. T. Koehler, Palo Alto, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110077265 | INHIBITORS OF IAP - The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds having the general formula U1-M-U2 wherein M is a linking group covalently joining R2, R3, R4 or R5 of U1 to an R2, R3, R4 or R5 group of U2; U1 and U2 have the general formula (I) and G, X1, X2, R2, R3, R3′, R4, R4′ and R5, are as described herein. | 03-31-2011 |
Ruth Koehler, Albany, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100047778 | Methylation Specific Primer Extension Assay for the Detection of Genomic Imprinting Disorders - Provided is a method for determining genomic imprinting disorders in a patient based upon methylation specific primer extension in a format amenable to high throughput and multiplex formats. After bisulfite modification of a genomic sample, DNA is amplified and hybridized to discrimination primers specific for a CpG dinucleotide site in the sample. Because no extension products from the discrimination primers are produced from DNA that has a deletion or functional inactivation at the CpG site, the sample may be diagnosed as having a genomic imprinting disorder by way of comparison with a normal sample. | 02-25-2010 |
Ryan T. Koehler, Hayward, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080228589 | Methods For Placing, Accepting, And Filling Orders For Products and Services - Methods and systems for ordering assays which detect SNPs or gene expression are provided. The methods use PCR and RT-PCR procedures. Collections of stock assays are assembled using pre- and post-manufacturing quality control procedures and made available to consumers via the Internet. In addition, custom assays are prepared upon order from the consumer and these assays are also prepared using pre- and post-manufacturing quality control procedures. The assays are then delivered to the consumer. | 09-18-2008 |